Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
Once-daily tiotropium Respimat add-on to ICS ± LABA improves control across asthma severitiesSchmidt, O ; FitzGerald, JM ; Kerstjens, H ; Paggiaro, P ; Ohta, K ; Ichinose, M ; Moroni-Zentgraf, P ; Engel, M ; Schmidt, H ; Bateman, EPneumologie, 2015, Vol.69 (S 01) [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Ata de Congresso
|
Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS)± long-acting β2-agonist (LABA): a randomized, double-blind, placebo-controlled studySchmidt, O ; Ohta, K ; Ichinose, M ; Tohda, Y ; Engel, M ; Moroni-Zentgraf, P ; Kunimitsu, S ; Sakamoto, W ; Adachi, MPneumologie, 2015, Vol.69 (S 01) [Periódico revisado por pares]Texto completo disponível |